JUDITA SLUSNYS: Open Payments
NPI 1770956476 · BOURBONNAIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,903 in 101 payments from 16 companies in 2025. Trend: 2023 $1,230 · 2024 $2,255 · 2025 $1,903
Food & beverage: $1,903
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $761 |
| GlaxoSmithKline, LLC. | 41 | $470 |
| Electromed, Inc. | 14 | $163 |
| Grifols USA, LLC | 4 | $108 |
| Insmed, Inc. | 5 | $78 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Actelion Pharmaceuticals US, Inc. | 2 | $43 |
| INOGEN, INC. | 3 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| GENZYME CORPORATION | 2 | $33 |
Products named: FASENRA, NUCALA, TEZSPIRE, SMARTVEST, Prolastin-C Liquid, TRELEGY ELLIPTA, DUPIXENT, Arikayce.
Industry payments across IL — which companies pay providers there.
